Showing results (91-100 of 282) with videos related to

Sort By:
Pageof 29
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal DysfunctionKoji Sasaki, Amit Lahoti, Elias Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 2, 2024
Outcome of Patients With Relapsed Acute Promyelocytic LeukemiaKoji Sasaki, Farhad Ravandi, Tapan Kadia, et al.
Cancer|February 18, 2010
Cause of death in patients with lower-risk myelodysplastic syndromeFarshid Dayyani, Anthony P Conley, Sara S Strom, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of MyelodysplasiaKoji Sasaki, Elias Jabbour, Jorge Cortes, et al.
Leukemia & Lymphoma|July 23, 2014
Myeloid neoplasms after breast cancer: "therapy-related" not an independent poor prognostic factorYiming Chen, Zeev Estrov, Sherry Pierce, et al.
Blood|November 25, 2003
PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survivalYoko Tabe, Marina Konopleva, Mark F Munsell, et al.
Cancer|July 29, 2015
Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsMusa Yilmaz, Amit Lahoti, Susan O'Brien, et al.
Cancer|July 22, 2026
Results of second-line therapy in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaHagop Kantarjian, Wei-Ying Jen, Eitan Kugler, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 12, 2016
Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML PatientsKoichi Takahashi, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Haematologica|July 2, 2013
Assessment at 6 months may be warranted for patients with chronic myeloid leukemia with no major cytogenetic response at 3 monthsAziz Nazha, Hagop Kantarjian, Preetesh Jain, et al.
Pageof 29